Author

S. Lecourt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Assay:ChIP-seq· 1 Assay:CRISPR screen· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

C. Lobry· 2 shared A. Anginot· 1 shared A. Bonaud· 1 shared A. Petit· 1 shared A. Puissant· 1 shared B. Pardieu· 1 shared B. Schell· 1 shared C. Freitas· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

C. Lobry

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CXCR4 signaling strength regulates hematopoietic multipotent progenitor fate through extrinsic and intrinsic mechanisms

V. Rondeau, M. Kalogeraki, L. Roland, Z. A. Nader, V. Gourhand, A. Bonaud, J. Lemos, M. Khamyath, C. Moulin, B. Schell, M. Delord, G. Bidaut, S. Lecourt, C. Freitas, A. Anginot, , K. Balabanian

This study shows that CXCR4 signaling strength influences hematopoietic multipotent progenitor fate through both extrinsic and intrinsic mechanisms, with implications for myeloid skewing in WHIM Syndrome.

bioRxiv · May 31, 2023 · PreprintCell Biology

Screening of clustered regulatory elements reveals functional cooperating dependencies in Leukemia.

S. Benbarche, C. K. Lopez, E. Salataj, C. Thirant, M.-C. Laiguillon, Z. Aid, S. Lecourt, M. Antonini, B. Pardieu, A. Petit, A. Puissant, J. Chaumeil, T. Mercher, C. Lobry

The paper identifies co-regulated genes in leukemia using CRISPRi screening of super-enhancer regions, showing that combined inhibition of KIT and PDGFRA synergizes to impair leukemia cell growth.

bioRxiv · Jun 24, 2019 · PreprintCancer Biology